Development requirements and regulatory guidance for biosimilars and biobetters.
Christina Satterwhite, PhD
Advertisement
Articles by Christina Satterwhite, PhD
Advertisement
Latest Updated Articles
Assessing Development Needs for Biobetters and BiosimilarsPublished: February 1st 2013 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
